CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 58 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,246,951 | +6.0% | 192,584 | -13.4% | 0.00% | 0.0% |
| Q2 2023 | $4,950,759 | -21.3% | 222,506 | -23.4% | 0.00% | 0.0% |
| Q1 2023 | $6,294,000 | +127748.9% | 290,592 | +19.9% | 0.00% | 0.0% |
| Q4 2022 | $4,923 | -99.9% | 242,446 | +4.5% | 0.00% | 0.0% |
| Q3 2022 | $5,950,000 | +9.4% | 232,011 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $5,439,000 | +11.8% | 228,715 | +5.8% | 0.00% | 0.0% |
| Q1 2022 | $4,866,000 | +16.4% | 216,081 | +2.4% | 0.00% | – |
| Q4 2021 | $4,179,000 | -59.5% | 211,045 | -59.8% | 0.00% | -100.0% |
| Q3 2021 | $10,325,000 | -28.9% | 524,622 | -20.5% | 0.00% | -50.0% |
| Q2 2021 | $14,515,000 | +220.8% | 659,783 | +246.9% | 0.00% | +100.0% |
| Q1 2021 | $4,525,000 | -13.2% | 190,194 | -4.5% | 0.00% | 0.0% |
| Q4 2020 | $5,212,000 | +179.2% | 199,245 | +87.3% | 0.00% | – |
| Q3 2020 | $1,867,000 | +75.8% | 106,353 | +68.6% | 0.00% | – |
| Q2 2020 | $1,062,000 | +119.9% | 63,076 | +55.6% | 0.00% | – |
| Q1 2020 | $483,000 | -1.8% | 40,532 | -0.4% | 0.00% | – |
| Q4 2019 | $492,000 | -6.1% | 40,703 | +10.0% | 0.00% | – |
| Q3 2019 | $524,000 | +39.7% | 37,014 | +10.0% | 0.00% | – |
| Q2 2019 | $375,000 | -79.5% | 33,641 | -78.4% | 0.00% | – |
| Q1 2019 | $1,827,000 | +363.7% | 155,674 | +428.2% | 0.00% | – |
| Q4 2018 | $394,000 | -74.8% | 29,470 | -73.5% | 0.00% | – |
| Q3 2018 | $1,561,000 | +47.5% | 111,409 | +65.7% | 0.00% | – |
| Q2 2018 | $1,058,000 | -71.8% | 67,240 | -70.5% | 0.00% | -100.0% |
| Q1 2018 | $3,747,000 | +17.8% | 227,758 | +29.3% | 0.00% | 0.0% |
| Q4 2017 | $3,182,000 | +3927.8% | 176,182 | +4159.7% | 0.00% | – |
| Q3 2017 | $79,000 | +203.8% | 4,136 | +88.9% | 0.00% | – |
| Q2 2017 | $26,000 | -80.2% | 2,189 | -81.7% | 0.00% | – |
| Q1 2017 | $131,000 | -74.2% | 11,947 | -82.9% | 0.00% | – |
| Q4 2016 | $507,000 | +1002.2% | 69,835 | +143.1% | 0.00% | – |
| Q3 2013 | $46,000 | -9.8% | 28,732 | -2.2% | 0.00% | – |
| Q2 2013 | $51,000 | – | 29,383 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |